Invesco’s Ascendis Pharma ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$163M Sell
947,226
-251,252
-21% -$43.4M 0.03% 699
2025
Q1
$187M Buy
1,198,478
+42,465
+4% +$6.62M 0.04% 638
2024
Q4
$159M Sell
1,156,013
-6,232
-0.5% -$858K 0.03% 693
2024
Q3
$174M Buy
1,162,245
+55,796
+5% +$8.33M 0.03% 657
2024
Q2
$151M Buy
1,106,449
+141,786
+15% +$19.3M 0.03% 662
2024
Q1
$146M Buy
964,663
+56,752
+6% +$8.58M 0.03% 687
2023
Q4
$114M Buy
907,911
+235,785
+35% +$29.7M 0.03% 714
2023
Q3
$62.9M Buy
672,126
+57,413
+9% +$5.38M 0.02% 866
2023
Q2
$54.9M Sell
614,713
-31,847
-5% -$2.84M 0.01% 914
2023
Q1
$69.3M Sell
646,560
-14,226
-2% -$1.53M 0.02% 833
2022
Q4
$80.7M Buy
660,786
+60,763
+10% +$7.42M 0.02% 772
2022
Q3
$62M Buy
600,023
+7,368
+1% +$761K 0.02% 826
2022
Q2
$55.1M Sell
592,655
-424,435
-42% -$39.5M 0.02% 891
2022
Q1
$119M Buy
1,017,090
+14,047
+1% +$1.65M 0.03% 703
2021
Q4
$135M Sell
1,003,043
-24,219
-2% -$3.26M 0.03% 680
2021
Q3
$164M Sell
1,027,262
-131,762
-11% -$21M 0.04% 600
2021
Q2
$152M Buy
1,159,024
+424,732
+58% +$55.9M 0.04% 651
2021
Q1
$94.6M Sell
734,292
-32,412
-4% -$4.18M 0.03% 833
2020
Q4
$128M Sell
766,704
-935
-0.1% -$156K 0.04% 619
2020
Q3
$118M Buy
767,639
+164,834
+27% +$25.4M 0.04% 570
2020
Q2
$89.2M Buy
602,805
+8,384
+1% +$1.24M 0.03% 640
2020
Q1
$66.9M Buy
594,421
+1,098
+0.2% +$124K 0.03% 669
2019
Q4
$82.5M Sell
593,323
-425,269
-42% -$59.2M 0.03% 761
2019
Q3
$98.1M Buy
1,018,592
+4,246
+0.4% +$409K 0.03% 667
2019
Q2
$117M Buy
1,014,346
+924,169
+1,025% +$106M 0.03% 616
2019
Q1
$10.6M Sell
90,177
-53,962
-37% -$6.35M ﹤0.01% 1534
2018
Q4
$9.03M Sell
144,139
-817
-0.6% -$51.2K ﹤0.01% 1589
2018
Q3
$10.3M Sell
144,956
-7,350
-5% -$521K ﹤0.01% 1681
2018
Q2
$10.1M Buy
+152,306
New +$10.1M ﹤0.01% 1652